Literature DB >> 2589381

Ciprofloxacin: toxicologic evaluation of additional safety data.

G Schluter1.   

Abstract

Long-term ciprofloxacin toxicology studies, additional data on arthorpathogenic effects, embryotoxicity studies in monkeys, and further results on central nervous system/interaction toxicology are presented. In the long-term studies of rats and mice, ciprofloxacin was given as food admixture in concentrations up to 5,000 ppm for 24 and 21 months, respectively. This treatment regimen did not result in any systemic toxicity and also did not give any indication of a tumorigenic effect of ciprofloxacin. In a study of juvenile dogs to investigate development of arthropathogenic lesions using magnetic resonance imaging techniques, an increase in width of the recessus suprapatellaris occurred only in those dogs in which marginal effects developed. Thus, this technique may be a suitable method to monitor juvenile patients receiving ciprofloxacin. Ciprofloxacin was also studied for its potential to act as an abortifacient when given orally or parenterally to cynomolgus monkeys. The data obtained did not give any indication of teratogenicity or embryolethality, and mean patterns of progesterone were similar between routes of administration, dose groups, and controls. Finally, data are presented that demonstrate that central nervous system interaction toxicity between quinolones and nonsteroidal anti-inflammatory drugs can be observed in rats only at therapeutically irrelevant high dose levels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2589381     DOI: 10.1016/0002-9343(89)90018-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones.

Authors:  Stephanie Padberg; Evelin Wacker; Reinhard Meister; Mary Panse; Corinna Weber-Schoendorfer; Marc Oppermann; Christof Schaefer
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

2.  The effects of ciprofloxacin on human chondrocytes in cell culture.

Authors:  M A Mont; S K Mathur; C G Frondoza; D S Hungerford
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

Review 3.  Fluoroquinolones in paediatrics.

Authors:  H S Jafri; G H McCracken
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 4.  Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy.

Authors:  W Connell; A Miller
Journal:  Drug Saf       Date:  1999-10       Impact factor: 5.606

Review 5.  Diagnosis and treatment of allergic rhinitis and sinusitis during pregnancy and lactation.

Authors:  Gary A Incaudo
Journal:  Clin Rev Allergy Immunol       Date:  2004-10       Impact factor: 8.667

Review 6.  Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts.

Authors:  G Maschmeyer
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 7.  Use of the quinolones in paediatrics.

Authors:  U B Schaad
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 8.  Use of quinolones in pediatrics.

Authors:  U B Schaad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 9.  Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation.

Authors:  V Chyský; K Kapila; R Hullmann; G Arcieri; P Schacht; R Echols
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

10.  Pregnancy Outcomes Following Exposure to Quinolone Antibiotics - a Systematic-Review and Meta-Analysis.

Authors:  Aviva Ziv; Reem Masarwa; Amichai Perlman; Danny Ziv; Ilan Matok
Journal:  Pharm Res       Date:  2018-03-26       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.